Related Experiment Video
Updated: May 27, 2026
08:03
Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022
Repetitive transplantation of different cell types sequentially improves heart function after infarction
Schuh Alexander1, Alexander Sasse, Simone Konschalla
1Department of Cardiology, Pulmonology, Angiology and Internal Medicine Intensive Care, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Journal of Cellular and Molecular Medicine
|November 5, 2011
Summary
Transplanting endothelial progenitor cells (EPCs) enhanced vascularization and improved heart function after myocardial infarction. Subsequent transplantation of fetal cardiomyocytes further boosted benefits, showing promise for cell therapy in regenerative medicine.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Cell-based Therapy
Background:
- Cell-based therapy offers a novel strategy for regenerative medicine.
- Poor survival of transplanted cells in ischemic environments limits therapeutic efficacy.
- Enhancing vascularization in infarcted areas is crucial for improving cell survival and function.
Purpose of the Study:
- To investigate methods for increasing the survival of transplanted cardiomyocytes.
- To augment vascular density in infarcted rat hearts using endothelial progenitor cells (EPCs).
- To evaluate the combined effect of EPCs and fetal cardiomyocytes on left ventricular function.
Main Methods:
- Injection of EPCs into infarcted rat hearts to improve vascularization.
- Subsequent transplantation of fetal cardiomyocytes.
- Serial echocardiography to assess left ventricular function.
- Histological analysis including BrdU, CFSE, and CD31 staining for cell detection and vessel density.
Main Results:
- EPC transplantation significantly improved left ventricular function.
- Subsequent transplantation of fetal cardiomyocytes provided an additive functional improvement.
- Histology confirmed increased vessel density and detected transplanted cells; however, increased apoptosis, proliferation, collagen, and neutrophil infiltration were also observed.
Conclusions:
- Combined cell therapy using EPCs and fetal cardiomyocytes significantly improves left ventricular function post-myocardial infarction in rats.
- Enhanced vascularization by EPCs supports the benefit of subsequent cardiomyocyte transplantation.
- Repetitive transplantation of different cell types represents a feasible strategy to enhance cell therapy outcomes for myocardial infarction.
